Selenium suppresses inflammation by inducing microRNA-146a in <i>Staphylococcus aureus</i>-infected mouse mastitis model
Weijing Sun(University of Kansas Medical Center), Mengyao Guo(Northeast Agricultural University)
Cited by 22
Related Papers
Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow
|Journal of Clinical Oncology|2003|293
Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin
|Clinical Cancer Research|2005|99
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
|Cancer|2011|97
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma
|Annals of Oncology|2013|89